A Study on the Prognostic Evaluation of Carbon Ion Radiotherapy for Head and Neck Adenocarcinoma with C-11 Methionine PET

Overview

Journal Mol Imaging Biol

Publisher Springer

Specialties Molecular Biology
Radiology

Date 2010 Apr 7

PMID 20369300

Citations 9

Authors

Mitsuhiko Hasebe

Kyosan Yoshikawa

Seiya Ohashi

Sachiko Toubaru

Koji Kawaguchi

Junichi Sato

Junetsu Mizoe

Hirohiko Tsujii

Affiliations

Soon will be listed here.

Abstract

Purpose: Carbon ion radiotherapy (CIRT) has been developed, and a phase I/II CIRT trial has been conducted in patients with adenocarcinoma in the head and neck region. We evaluated whether the L-methyl [11C]-methionine (MET) uptake could be an early predictor for local recurrence, metastasis, and the prognosis in patients with adenocarcinoma in the head and neck region.

Methods: Twenty-six patients were prospectively studied by MET-positron emission tomography (PET) before and about 1 month after CIRT. The tumor MET uptake was measured with the semiquantitative tumor to normal tissue ratio (TNR). The tumor TNR and relevant clinical parameters were then evaluated by both univariate and multivariate analyses.

Results: The average TNRs before and after the treatment were 6.2 (± 2.2) and 3.9 (± 1.7), respectively, and significant differences were observed between them. In a univariate analysis, both local recurrence and metastasis were observed more frequently in the group with a higher TNR before and after the treatment than a lower TNR, and the prognosis was also poor. The cut-off values were 9.3, 4.9, and 5.1 before the treatment and 4.9, 4.2, and 4.3 after the treatment, respectively. In the rate of TNR changes before and after the treatment, metastasis was observed more frequently in the group with lower rates of change, and the prognosis was poor. The cut-off values for metastasis and prognosis determination were 18.0% and 16.9%, respectively. In a multivariate analysis, significant differences were observed for all relationships except for the relationship between the TNR before the treatment and local recurrence. Significant differences were observed for metastasis and prognosis in the rate of TNR changes before and after the treatment.

Conclusions: The determination of treatment effectiveness using TNR in CIRT for head and neck adenocarcinoma is an independent factor for predicting local recurrence, the incidence of metastasis, and the prognosis. MET-PET is therefore considered to be useful for determining the treatment effectiveness in patients with head and neck adenocarcinoma undergoing CIRT.

Citing Articles

Role of F-FDG PET/CT in Head and Neck Squamous Cell Carcinoma: Current Evidence and Innovative Applications.

Caldarella C, De Risi M, Massaccesi M, Micciche F, Bussu F, Galli J Cancers (Basel). 2024; 16(10).

PMID: 38791983 PMC: 11119768. DOI: 10.3390/cancers16101905.

[S-methyl-C]-L-methionine positron emission tomography/computed tomography imaging parameters to evaluate early response for esophageal cancer with neoadjuvant carbon ion radiotherapy.

Narushima K, Nishii R, Okazumi S, Shimada H, Akutsu Y, Maeda T Sci Rep. 2022; 12(1):13694.

PMID: 35953702 PMC: 9372167. DOI: 10.1038/s41598-022-17962-x.

Potential role of functional imaging in predicting outcome for patients treated with carbon ion therapy: a review.

Riva G, Imparato S, Savietto G, Pecorilla M, Iannalfi A, Barcellini A Br J Radiol. 2021; 94(1128):20210524.

PMID: 34520670 PMC: 8631012. DOI: 10.1259/bjr.20210524.

Adenoid cystic carcinoma: focus on heavy ion therapy and molecular imaging.

Castello A, Olivari L, Lopci E Am J Nucl Med Mol Imaging. 2018; 8(1):1-14.

PMID: 29531857 PMC: 5840319.

Positron Emission Tomography Imaging of Tumor Cell Metabolism and Application to Therapy Response Monitoring.

Challapalli A, Aboagye E Front Oncol. 2016; 6:44.

PMID: 26973812 PMC: 4770188. DOI: 10.3389/fonc.2016.00044.

References

Blakely E . Cell inactivation by heavy charged particles. Radiat Environ Biophys. 1992; 31(3):181-96. DOI: 10.1007/BF01214826. View

Stern P, Wallace C, Hoffman R . Altered methionine metabolism occurs in all members of a set of diverse human tumor cell lines. J Cell Physiol. 1984; 119(1):29-34. DOI: 10.1002/jcp.1041190106. View

Lindholm P, Grenman R, Lehikoinen P, Nagren K, Teras M, Ruotsalainen U . Evaluation of response to radiotherapy in head and neck cancer by positron emission tomography and [11C]methionine. Int J Radiat Oncol Biol Phys. 1995; 32(3):787-94. DOI: 10.1016/0360-3016(95)00007-L. View

Bergstrom M, Muhr C, Lundberg P, Langstrom B . PET as a tool in the clinical evaluation of pituitary adenomas. J Nucl Med. 1991; 32(4):610-5. View

Hoffman R . Unbalanced transmethylation and the perturbation of the differentiated state leading to cancer. Bioessays. 1990; 12(4):163-6. DOI: 10.1002/bies.950120404. View

Hoffman R . Altered methionine metabolism, DNA methylation and oncogene expression in carcinogenesis. A review and synthesis. Biochim Biophys Acta. 1984; 738(1-2):49-87. DOI: 10.1016/0304-419x(84)90019-2. View

Jansson T, Westlin J, Ahlstrom H, Lilja A, Langstrom B, Bergh J . Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?. J Clin Oncol. 1995; 13(6):1470-7. DOI: 10.1200/JCO.1995.13.6.1470. View

Laramore G, Krall J, Griffin T, Duncan W, Richter M, Saroja K . Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council. Int J Radiat Oncol Biol Phys. 1993; 27(2):235-40. DOI: 10.1016/0360-3016(93)90233-l. View

Teshima T, Inoue T, Ikeda H, Yamazaki H, Ohtani M, Shimizutani K . Radiation therapy for carcinoma of the major salivary glands. Results of conventional irradiation technique. Strahlenther Onkol. 1993; 169(8):486-91. View

10.

Zhang H, Yoshikawa K, Tamura K, Sagou K, Tian M, Suhara T . Carbon-11-methionine positron emission tomography imaging of chordoma. Skeletal Radiol. 2004; 33(9):524-30. DOI: 10.1007/s00256-004-0815-5. View

11.

Landau . StatView for Windows, Version 5.0. Stat Methods Med Res. 2000; 8(4):337-41. DOI: 10.1177/096228029900800411. View

12.

Tsuyuguchi N, Hakuba A, Okamura T, Ochi H, Suzuki T, Sunada I . PET for diagnosis of malignant lymphoma of the scalp: comparison of [11C]methyl-L-methionine and [18F]fluoro-2-deoxyglucose. J Comput Assist Tomogr. 1997; 21(4):590-3. DOI: 10.1097/00004728-199707000-00011. View

13.

Tsukuda M, Kokatsu T, Ito K, Mochimatsu I, Kubota A, Sawaki S . Chemotherapy for recurrent adeno- and adenoidcystic carcinomas in the head and neck. J Cancer Res Clin Oncol. 1993; 119(12):756-8. DOI: 10.1007/BF01195348. View

14.

Kato T, Shinoda J, Nakayama N, Miwa K, Okumura A, Yano H . Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography. AJNR Am J Neuroradiol. 2008; 29(6):1176-82. PMC: 8118839. DOI: 10.3174/ajnr.A1008. View

15.

Tsujii H, Mizoe J, Kamada T, Baba M, Tsuji H, Kato H . Clinical Results of Carbon Ion Radiotherapy at NIRS. J Radiat Res. 2007; 48 Suppl A:A1-A13. DOI: 10.1269/jrr.48.a1. View

16.

Kanai T, Endo M, Minohara S, Miyahara N, Koyama-Ito H, Tomura H . Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. Int J Radiat Oncol Biol Phys. 1999; 44(1):201-10. DOI: 10.1016/s0360-3016(98)00544-6. View

17.

Zhang H, Yoshikawa K, Tamura K, Tomemori T, Sagou K, Tian M . [(11)C]methionine positron emission tomography and survival in patients with bone and soft tissue sarcomas treated by carbon ion radiotherapy. Clin Cancer Res. 2004; 10(5):1764-72. DOI: 10.1158/1078-0432.ccr-0190-3. View

18.

TOBIAS C, Blakely E, Alpen E, Castro J, AINSWORTH E, Curtis S . Molecular and cellular radiobiology of heavy ions. Int J Radiat Oncol Biol Phys. 1982; 8(12):2109-20. DOI: 10.1016/0360-3016(82)90554-5. View

19.

Sato K, Kameyama M, Kayama T, Yoshimoto T, Ishiwata K, Ito M . Serial positron emission tomography imaging of changes in amino acid metabolism in low grade astrocytoma after radio- and chemotherapy-- Case report. Neurol Med Chir (Tokyo). 1995; 35(11):808-12. DOI: 10.2176/nmc.35.808. View

20.

Chesnay E, Babin E, Constans J, Agostini D, Bequignon A, Regeasse A . Early response to chemotherapy in hypopharyngeal cancer: assessment with (11)C-methionine PET, correlation with morphologic response, and clinical outcome. J Nucl Med. 2003; 44(4):526-32. View